newsfilter
← Latest News
GlobeNewswire·

Alterity Therapeutics Announces Multiple Oral and Poster Presentations to be Featured at the International MSA Congress

MELBOURNE, Australia and SAN FRANCISCO, May 07, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) ("Alterity" or "the Company"), a biotechnology company dedicated to developing disease modifying